Article Details
Retrieved on: 2025-03-07 19:45:31
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Brokerage Morgan Stanley starts coverage on drug developer Crinetics NASDAQ:CRNX, which focuses on developing treatments for hormonal disorders, ...
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here